PERSPECTA

News from every angle

← Back to headlines

TD Cowen Cautious on Amicus Therapeutics Despite Positive Revenue Projections

TD Cowen maintains a cautious outlook on Amicus Therapeutics (FOLD) even with positive revenue projections for 2025.

19 Feb, 00:38 — 19 Feb, 00:38
PostShare
Only 1 source covers this story